XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel · Delayed Price · Currency is ILS · Price in ILA 2.000
0.00 (0.00%)
Apr 24, 2026, 1:44 PM IDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of 18.92 million as of April 24, 2026. Its market cap has decreased by -69.21% in one year.
Market Cap
18.92M
Enterprise Value
18.34M
Revenue
3.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.00
Market Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 18.92M, a decrease of -97.65%. That is a compound annual growth rate of -16.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 18.92M | -16.67% |
| Dec 31, 2025 | 22.71M | -72.15% |
| Dec 31, 2024 | 81.53M | 327.50% |
| Dec 31, 2023 | 19.07M | -14.63% |
| Dec 29, 2022 | 22.34M | -52.02% |
| Dec 30, 2021 | 46.56M | -7.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 495.29M |
| Geffen Residence & Renewal | 257.44M |
| Matricelf | 92.74M |
| Clal Biotechnology Industries | 50.66M |
| BioLineRx | 33.94M |
| Evogene | 29.17M |
| Can-Fite BioPharma | 19.82M |
| BioLight Life Sciences | 19.45M |